Cyclerion Therapeutics Inc. (NASDAQ: CYCN) Expands its Partnership With Beacon Biosignals

July 26, 2021

Cyclerion Therapeutics Inc. (NASDAQ: CYCN) has announced an expansion and extended its strategic partnership with Beacon Biosignals. The partnership will identify disease-relevant biomarkers refining patient selection as well as endpoints to guide Cyclerion’s clinical development of experimental therapies for cognitive impairment-related neurological diseases. Cyclerion to leverage Beacon Biosignals’ EEG tech The EEG neurobiomarker technology from Beacon Biosignals is designed to find and scale novel therapeutic models for psychiatric and neurological…

Read More >>